WHO Sounds Warning Over Critical Lack of Weight-Loss Medications

Under a tenth of patients who could benefit from weight-loss injections like Wegovy can access them, caution the WHO as it issues its inaugural advice on the drugs.

Given in excess of 1,000,000,000 people worldwide now living with obesity, it is advocating for broader and more equitable access to these injectable treatments.

Per estimates, in excess of 2,000,000,000 could be obese by 2030 unless action is taken.

"Our new guidelines affirms that excess weight is a long-term condition that can be treated with thorough and ongoing care," said WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are significant barriers to broad access to the jabs that can aid individuals in losing substantial weight, notes the organization.

GLP-1 Therapy Scarcity

Even under the current most optimistic case, the supply of these medications might only reach approximately 100 million people – less than 10% of those who need them, as stated by the health organization.

The guideline urges governments and firms to widen access, through measures such as voluntary licensing.

The intellectual property rights on the active ingredient – the core component of a leading brand – is scheduled to end in multiple nations in 2026.

How Weight-Loss Jabs Operate

GLP-1 drugs imitate a biological compound to delay gastric emptying, suppress the appetite and increase feelings of fullness so individuals consume fewer calories.

People usually begin shedding pounds in the initial weeks of commencing the regular doses.

Research points to people may regain a significant portion within a year of discontinuing the treatment, because their normal appetite come back.

To be carrying excess weight increases your likelihood for experiencing health problems, like type 2 diabetes, heart disease, brain attack, and some malignancies.

Obesity concerns people in countries worldwide and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.